Nine of 100 never-smoker patients with SCLC had genomic data, showing that never-smokers were characterized by a lower tumor mutation burden, fewer TP53 mutations, and absence of mutational signatures associated with tobacco exposure. The gene discussed is TP53; the disease is neoplasm.